Danaher Corporation (FRA:DAP)
Germany
· Delayed Price · Currency is EUR | Market Cap | 124.89B |
| Revenue (ttm) | 21.99B |
| Net Income (ttm) | 3.48B |
| Shares Out | n/a |
| EPS (ttm) | 4.76 |
| PE Ratio | 35.93 |
| Forward PE | n/a |
| Dividend | 1.05 (0.61%) |
| Ex-Dividend Date | Mar 28, 2025 |
| Volume | 367 |
| Average Volume | 995 |
| Open | 174.98 |
| Previous Close | 173.26 |
| Day's Range | 173.86 - 175.74 |
| 52-Week Range | 149.72 - 260.00 |
| Beta | n/a |
| RSI | 46.92 |
| Earnings Date | Apr 22, 2025 |
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manuf... [Read more]
Financial Performance
In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.
Financial numbers in USD Financial StatementsNews
Baron Health Care Fund Q1 2025 Top Contributors And Detractors
Boston Scientific's shares rose due to strong market growth, innovative products like pulsed field ablation, and disciplined cost management, driving double-digit EPS growth. Vertex Pharmaceuticals sa...
Kytopen and Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative CRISPR-mediated Cellular Engineering Workflow
Kytopen and Aldevron announce collaboration to expedite cell therapy manufacturing by combining their novel technologies. High transgene expression and improved safety profile of Aldveron's Nanoplasmi...
Analyst Sees Opportunity In Danaher Stock As Sentiment Improves
Danaher Corp (NYSE: DHR) on Tuesday reported first-quarter 2025 sales of $5.74 billion, down 1% year-over-year, beating the consensus of $5.59 billion . Non-GAAP core revenue was flat compared to the...
Three ideas to invest amid the trade war
Dan Rohinton, portfolio manager at iA Global Asset Management, has three ideas to invest amid the trade war: Danaher, GE Aerospace & CME Group.
Danaher's quarterly results show signs of life, and the struggling stock soars
Count us among the Danaher investors breathing a sigh of relief.
Danaher outlines 3% core revenue growth and $7.60-$7.75 EPS guidance for 2025
Danaher Corporation 2025 Q1 - Results - Earnings Call Presentation
The following slide deck was published by Danaher Corporation in conjunction with their 2025 Q1 earnings call.
Danaher Corporation (DHR) Q1 2025 Earnings Call Transcript
Danaher Corporation (NYSE:DHR) Q1 2025 Earnings Conference Call April 22, 2025 8:00 AM ETCompany ParticipantsJohn Bedford - VP, IRRainer Blair - President...
Quest Diagnostics Posts Better-Than-Expected Earnings, Joins Pentair, 3M, Danaher And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones index gaining around 600 points on Tuesday. Shares of Quest Diagnostics Incorporated (NYSE: DGX) rose sharply during Tuesday's session following better-tha...
Danaher Makes A Bullish Move On 'Solid' Report, Promising Tariffs Plan
Danaher stock jumped Tuesday after the medical powerhouse delivered a "solid" first-quarter report and maintained its outlook for the year.
Danaher Beats Q1 Expectations, Signals Caution Ahead In 'Unusual Times'
Danaher Corp (NYSE: DHR) on Tuesday reported first-quarter 2025 sales of $5.74 billion, down 1% year-over-year, beating the consensus of $5.59 billion . Non-GAAP core revenue was flat compared to the...
Danaher Beats Q1 Expectations, Signals Caution Ahead In 'Unusual Times'
Danaher Corp DHR on Tuesday reported first-quarter 2025 sales of $5.74 billion, down 1% year-over-year, beating the consensus of $5.59 billion.
Danaher projects in line guidance despite Q1 beat
Danaher beats quarterly profit, expects incremental costs from US tariffs
Danaher beat Wall Street estimates for first-quarter profit on Tuesday, on the back of better-than-expected demand for its respiratory testing kits, and said it expects to incur additional tariff-rela...
Earnings Snapshot: Danaher tops Q1 estimates; initiates FY25 EPS and Q2 outlook
Danaher Non-GAAP EPS of $0.88 misses by $0.76, revenue of $5.74B beats by $150M
Danaher Non-GAAP EPS of $1.88 beats by $0.24, revenue of $5.74B beats by $150M
Danaher Reports First Quarter 2025 Results
WASHINGTON , April 22, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended March 28, 2025. Key First Quarter 2025 Results Net earnings we...
Danaher Q1 2025 Earnings Preview
Earnings Outlook For Danaher
Danaher (NYSE: DHR) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-22. Here's a quick overview of what investors should know before the release. Analysts are estimating that Dan...
US stocks are set to open lower
Major US stock indices are set a low below. Nvidia shares are back below the 100 level as concerns about global trade heighten anxiety. Shares of Netflix are higher after their earnings announcement a...
$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
Danaher (NYSE: DHR) has outperformed the market over the past 10 years by 2.96% on an annualized basis producing an average annual return of 12.55%. Currently, Danaher has a market capitalization of ...
Smart Money Is Betting Big In DHR Options
Whales with a lot of money to spend have taken a noticeably bullish stance on Danaher . Looking at options history for Danaher (NYSE: DHR) we detected 8 trades. If we consider the specifics of each t...
Lightning Round: Robinhood has more downside from here, says Jim Cramer
'Mad Money' host Jim Cramer weighs in on stocks including: Archer Aviation, GlobalFoundries, Dow, Old Republic International, Danaher, Robinhood, and more.
3 Wide-Moat Dividend Stars For A Championship Portfolio
I linked investing to baseball, showing how consistency, like the A's Moneyball approach, wins long term. Steady dividend growers and low-volatility stocks outperform, especially in rocky markets. Top...